Comment on: Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate quality-adjusted life-years. [BioDrugs. 2015] The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy. [BioDrugs. 2014]
Reply to Scalone and Cortesi : Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy : The importance of using updated and adequate social tariffs to calculate QALYs / F. Spandonaro, F. Ayala, E. Berardesca, S. Chimenti, G. Girolomoni, P. Martini, A. Peserico, B. Polistena, A.P. Guerra, G.A. Vena, G. Altomare, P.C. Pinton. - In: BIODRUGS. - ISSN 1173-8804. - 29:1(2015 Feb), pp. 71-72. [10.1007/s40259-015-0118-5]
Reply to Scalone and Cortesi : Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy : The importance of using updated and adequate social tariffs to calculate QALYs
G. AltomarePenultimo
;
2015
Abstract
Comment on: Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate quality-adjusted life-years. [BioDrugs. 2015] The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy. [BioDrugs. 2014]
| File | Dimensione | Formato | |
|---|---|---|---|
|
art%3A10.1007%2Fs40259-015-0118-5.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
146.23 kB
Formato
Adobe PDF
|
146.23 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
